Christine Desbiens
Chercheuse associée
Axe Oncologie
Publications
View all-
article Fiore JF, Shirzadi S, Roversi K, Prakash I, Wong S, Meterissian S, Meguerditchian AN, Desbiens C, Rivard J, Delisle M, Findlay-Shirras L, Abou Khalil J, Maciver A, Quan ML, Verreault K, Johnston S, Feldman L, McDonald EG and
Comparative effectiveness of opioid versus opioid-free analgesia after outpatient breast surgery: PAIN-Alt trial protocol
BMJ Open 15 (11), 2025.
-
article Joy AA, Cheng N, Gelmon KA, Mates M, Desbiens C, Clemons M, Taylor S, Lemieux J, DeLuca A, Gasparini L, Lungu I, Soave D, Fortuna A, Pugh T, Liu SS, Bartlett JMS, Awadalla P, Spears M, Chen BE, Bayani J, Parulekar WR
Continuous vs. Standard Palbociclib Treatment and Molecular Profiling of Solid Tissues and Liquid Biopsies in the CCTG MA.38 Trial in Advanced Breast Cancer
Cancer Res Commun 5 (11), 2025.
-
article Gauthier V, Simard AJ, Desbiens C, Poirier B, Boudreau D, Leblanc D, Morin C, Hogue JC, Poirier É
Neoadjuvant chemotherapy in invasive lobular carcinoma of the breast: perspectives based on the survival outcomes
Front Oncol 15 2025.
Projects
- Vers des trajectoires de soins en cancer du sein personnalisées en fonction du risque et des besoins des patientes: une étude de faisabilité et d'acceptabilité, from 2023-04-01 to 2026-07-31
- COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib , from 2024-03-12 to 2029-12-25
- Comparative effectiveness of opioid versus opioid-free post-discharge analgesia after outpatient breast surgery: A randomized controlled trial, from 2024-07-23 to 2029-12-25
- NSABP Breast Cancer Treatment Protocols, from 1997-02-01 to 2025-12-25
- OptimICE-pCR: De-escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR after Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy , from 2024-04-26 to 2025-02-28
- From survival to quality of life: developing and implementing priorities- and values-based personalized supportive and rehabilitation care pathways with and for people with advanced breast cancer, from 2024-07-15 to 2024-10-15